Resources from the same session
4093 - FORWARD I (GOG 3011): A Phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
Presenter: Kathleen Moore
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
4101 - Lenvatinib (LEN) and Pembrolizumab (PEMBRO) in Advanced Endometrial Cancer (EC)
Presenter: Vicky Makker
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
2738 - A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian or Peritoneal Cancer
Presenter: David Gershenson
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
5630 - Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
Presenter: Robert Naumann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Gynaecological cancers - Invited Discussant LBA62 and 994O
Presenter: Nicoletta Colombo
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Slides
Webcast